Meeting the Formidable Challenges of Strategic Sourcing: Building a Virtual Infrastructure for Drug Development and Commercialization BSMA Panel - April 26, 2017 Moderator: Mary Kachinsky FORMA Therapeutics VP Strategic Sourcing and Operations

Meet the Panel Members Matt Weinberg Director, Strategic Sourcing Agios 10+ years’ strategic sourcing experience across diverse indirect categories Procurement team leader for fast-growing biotech Kimberly Lounds Foster Corporate VP of Global Supply Celgene 20+ years experience in pharma operations, merger & acquisitions, strategic planning Experience from Big Pharma, Biotech, CAR-T, Generic and in contract manufacturing Stephany Lapierre Founder and CEO tealbook Entrepreneur with 15 years’ healthcare industry experience Sourcing expert for 50 of the industry’s leading companies Has efficiently managed more than 500 supplier searches across all healthcare functions John Napoli Director, Information Services, Perkin Elmer Thought Leader, Strategist, Leader for cutting edge IT Managed Service Programs in the BioPharma industry Business Process Transformation Change Manager Specialist w/ 35 years experience in Platform Maturity for Lab IT environments.

Access to Assets, Not Ownership of Assets “Say I were to give you the following challenge: Create an organization that could compete head-to-head with any Fortune 500 company, without investing in any assets that you yourself owned. Thirty years ago, this would have been a preposterous proposition. Today, it is completely feasible. Increasingly, our world is one in which one pays for access to the assets one needs, rather than having to own them outright.” Rita Gunther McGrath, The End of Competitive Advantage (2013), page 95.

Building a Virtual Competitive Advantage Tap in to a broader network of providers Harvest value through creative “deal making” Engage in a collaborate partnership centered around trust Hire a skilled team to manage your supply network Create a culture that supports risk Shift your thinking from a hierarchical to a symbiotic model A well defined and orchestrated supply chain will minimize risk and maximize the the potential for competitive advantage.

Panel Questions & Discussion

Panel Members Matt Weinberg Director, Strategic Sourcing Agios 10+ years’ strategic sourcing experience across diverse indirect categories Procurement team leader for fast-growing biotech Kimberly Lounds Foster Corporate VP of Global Supply Celgene 20+ years experience in pharma operations, merger & acquisitions, strategic planning Experience from Big Pharma, Biotech, CAR-T, Generic and in contract manufacturing Stephany Lapierre Founder and CEO tealbook Entrepreneur with 15 years’ healthcare industry experience Sourcing expert for 50 of the industry’s leading companies Has efficiently managed more than 500 supplier searches across all healthcare functions John Napoli Director, Information Services, Perkin Elmer Thought Leader, Strategist, Leader for cutting edge IT Managed Service Programs in the BioPharma industry Business Process Transformation Change Manager Specialist w/ 35 years experience in Platform Maturity for Lab IT environments.